Nalini Rajamannan, MD
Nalini Rajamannan, MD, is the Council Chair of Valvular Disease for CorVita Science Foundation (CSF).
Nalini Rajamannan, MD, is an expert in valvular heart disease, echocardiography and risk factors for cardiovascular disease including lipid disorders and hypertension. She currently serves as the Medical Director at Sacred Cardiology where her goal is to work with patient’s personal physician to provide outpatient consultative specialized cardiology services in the fields of valvular medicine, primary and secondary prevention of heart disease. Dr. Rajamannan collaborates with several providers for inpatient hospital testing in the greater Wisconsin area, including Bellin Hospital, Green Bay, WI, and in the city Rochester, Minnesota at Mayo Clinic.
Dr. Rajamannan is a US citizen, born in Minnesota and her Christian faith guides her actions. She received a Catholic education from grade school through college. She completed her undergraduate studies with high honors from the University of Notre Dame, South Bend, IN. Her Medical Degree comes from Mayo Medical School in Rochester MN. Her studies of the heart began in 1987. She trained in Internal Medicine and Cardiology and went on to complete post graduate training in Level III Echocardiography at the Mayo Clinic. She combined her post graduate clinical training with three years of research as a Fellow on the Mayo Clinic’s National Institute of Health Research Training program in Cardiovascular Diseases. She maintains her Board Certification in Cardiovascular Disease for the American Board of Internal Medicine.
Dr. Rajamannan has already made a significant impact on the national and international levels as a lecturer on the molecular biology of valvular heart disease. In addition, her research has been acknowledged by the National Institute of Health’s (NIH) Heart, Lung, and Blood Institute, where she was the Chair of the working group of Valvular Heart Disease (click here).
Her research and clinical interest focus on valvular heart disease, specifically aortic stenosis and mitral regurgitation; use of echocardiography to diagnose and treat valvular heart disease; and evaluating risk factors that are important in the progression of these diseases. She has authored several book chapters and two books in the field of valvular heart disease. One recently published book is the scholarly work Cardiac Valvular Medicine. She also serves on editorial boards, and has published seminal papers in the field of valvular heart disease.